Chimeric antigen receptor T-cell therapy for multiple myelomaZehua Wang(First Affiliated Hospital of Zhengzhou University), Yanru Qin(Zhengzhou University)Frontiers in ImmunologyDecember 22, 202210.3389/fimmu.2022.1050522Cited by 21SaveCiteExport RISWatch citationsRelated PapersPredictive significance of STK17A in patients with gastric cancer and association with gastric cancer cell proliferation and migration|Oncology Reports|2021|8Development of multifunctional celastrol nanoparticles to enhance antitumor effects by interfering with the function of mitochondria in breast cancer|Research Square|2022|0